tiprankstipranks
Medexus Pharmaceuticals Inc (TSE:MDP)
TSX:MDP
Canadian Market
MDP
Medexus Pharmaceuticals Inc
RESEARCH TOOLSreports
Want to see TSE:MDP full AI Analyst Report?

Medexus Pharmaceuticals Inc (MDP) Stock News & Sentiment

67 Followers
Medexus Advances U.S. GRAFAPEX Rollout While Streamlining Capital Structure
Premium
Company Announcements
Medexus Advances U.S. GRAFAPEX Rollout While Streamlining Capital Structure
22d ago
Medexus Pharmaceuticals: Channel Headwinds Masking Demand as Strategic Positioning Supports Buy-Rated Risk‑Reward
Premium
Ratings
Medexus Pharmaceuticals: Channel Headwinds Masking Demand as Strategic Positioning Supports Buy-Rated Risk‑Reward
3M ago
Medexus Pharmaceuticals Balances GRAFAPEX Growth With Headwinds
Premium
Company Announcements
Medexus Pharmaceuticals Balances GRAFAPEX Growth With Headwinds
3M ago
Is MDP a Buy, Before Earnings?
Premium
Pre-Earnings
Is MDP a Buy, Before Earnings?
3M ago
Medexus Sets Date for Q3 2026 Earnings Call and Webcast
Premium
Company Announcements
Medexus Sets Date for Q3 2026 Earnings Call and Webcast
3M ago
Medexus Pharmaceuticals Inc.: Stable Growth and Promising Outlook Justify Buy Rating
Premium
Ratings
Medexus Pharmaceuticals Inc.: Stable Growth and Promising Outlook Justify Buy Rating
6M ago
Medexus Secures New Credit Facilities and Plans Share Buyback
Premium
Company Announcements
Medexus Secures New Credit Facilities and Plans Share Buyback
6M ago
More TSE:MDP News >

MDP News on the Web

Medexus Advances U.S. GRAFAPEX Rollout While Streamlining Capital Structure
TipRanks News
Neutral
Medexus Pharmaceuticals: Channel Headwinds Masking Demand as Strategic Positioning Supports Buy-Rated Risk‑Reward
TipRanks News
Bullish
Medexus Pharmaceuticals Balances GRAFAPEX Growth With Headwinds
TipRanks News
Bullish
Is MDP a Buy, Before Earnings?
TipRanks News
Neutral
Raymond James Sticks to Its Buy Rating for Medexus Pharmaceuticals Inc (MDP)
TipRanks News
Neutral
Medexus Pharmaceuticals Announces Fiscal Year 2025 Financial Results Conference Call
TipRanks News
Neutral
Raymond James Reaffirms Their Buy Rating on Medexus Pharmaceuticals Inc (MDP)
TipRanks News
Bullish
Medexus Pharmaceuticals to Discuss Q3 2025 Results in Upcoming Conference Call
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
TSE:MDP
Sector Average
Media Buzz
Currently, no data available
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:MDP’s Media Buzz Sentiment?
Currently, no data Available
What is TSE:MDP’s weekly average amount of articles?
Currently, no data Available
What is TSE:MDP’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
TVTXTravere Therapeutics
HVOOpen Orphan Plc
PBMPsyence Biomedical
QDELQuidelOrtho
Showing the stocks with the most bullish news sentiment over the past week